Concepedia

Mélanie Demeules

MD

6

Publications

212

Citations

6

H-Index

2020

Active since

Affiliations

Inserm(Current)

Université de Rouen Normandie

Normandie Université

Universität Hamburg

University Medical Center Hamburg-Eppendorf

Mélanie Demeules is an author at Inserm specializing in pharmacology, theranostics, and tumor biology.

ORCID

Top concepts

Publications per year

2020–2024

6

Publications

6

CD11c+ B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy Donors

Marie-Laure Golinski, Mélanie Demeules, Céline Derambure et al. · Frontiers in Immunology · 2020 · 144 citations · Full text

Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)

Mélanie Demeules, Allan Scarpitta, Catalina Abad et al. · Frontiers in Oncology · 2020 · 18 citations · Full text

, , +17

Dual molecule targeting HDAC6 leads to intratumoral CD4+ cytotoxic lymphocytes recruitment through MHC-II upregulation on lung cancer cells

Sarah Ducellier, Mélanie Demeules, Boris Letribot et al. · Journal for ImmunoTherapy of Cancer · 2024 · 18 citations · Full text

A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7 In Vivo

Henri Gondé, Mélanie Demeules, Romain Hardet et al. · Frontiers in Immunology · 2021 · 12 citations · Full text

Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy

Ann‐Christin Franke, Romain Hardet, Lisa Prager et al. · Molecular Therapy — Methods & Clinical Development · 2023 · 10 citations · Full text

Rows per page

1–5 of 6